Additionally, it slows gastric emptying, which prolongs feelings of fullness and reduces hunger, leading to lower calorie intake and weight loss
Launched by Novo Nordisk in 2026, oral semaglutide stands out as the first oral GLP-1 medication approved specifically for weight loss
Our entire program is built on a foundation of medical expertise, safety, and unwavering patient support
Daily stool softeners, regular polyethylene glycol use several times weekly, strict adherence to high fiber and hydration, and regular physical activity become permanent lifestyle elements
The FDA also approved Wegovy for weight loss in people who are obese (have a body mass index [BMI] of 30 or greater) or overweight (have a BMI of 27 or greater) and have at least one weight-related health condition
fat burning)